Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model

Kidney International

Volumn 41, Issue 2, 1992, Pages 297-309

  Floege, Jürgen ^a   Burns, Mark W ^b   Alpers, Charles E ^b   Yoshimura, Ashio ^b   Pritzl, Pamela ^b   Gordon, Katherine ^b   Seifert, Ronald A ^b   Bowen Pope, Daniel F ^b   Couser, William G ^b   Johnson, Richard J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; DEVELOPMENT; GLOMERULOSCLEROSIS; GLOMERULUS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE;

ACTINS; ANIMAL; BLOOD PLATELETS; CELL DIVISION; CELL MOVEMENT; GENE EXPRESSION; GLOMERULAR MESANGIUM; GLOMERULOSCLEROSIS, FOCAL; KIDNEY GLOMERULUS; LEUKOCYTES; MALE; MUSCLE, SMOOTH; NEPHRECTOMY; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, INBRED STRAINS; RECEPTORS, CELL SURFACE; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026541019     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1992.42     Document Type: Article

References (69)

1. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
2. CHANUTIN A, FERRIS EB: Experimental renal insufficiency produced by partial nephrectomy I. Control diet. Arch Int Med 49:767-772, 1932
3. PURKERSON ML, HOFFSTEN PE, KLAHR S: Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 9:407-417, 1976
4. OLIVETTI G, ANVERSA P, RIGAMONTI W, VITALI-MAZZA L, LOUD AV: Morphometry of the renal corpuscle during normal postnatal growth and compensatory hypertrophy. J Cell Biol 75:573-580, 1977
5. SHEA SM, RASKOVA J, MORRISON AB: A stereologic study of glomerular hypertrophy in the subtotally nephrectomized rat. Am J Pathol 90:201-210, 1978
6. OLSON JL, HOSTETTER TH, RENNKE HG, BRENNER BM, VENKATACHALAM MA: Mechanisms of altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 22:112-116, 1982
7. MEYER TW, BRENNER BM: The contribution of glomerular hemodynamic alterations to progressive renal disease, in The Progressive Nature of Renal Disease, edited by MITCH WE, BRENNER BM, STEIN JH, New York, Churchill Livingstone, 1986, pp. 1-16
8. FOGO A, ICHIKAWA I: Evidence for the central role of glomerular growth promoters in the development of sclerosis. Sem Nephrol 9:329-342, 1989
9. RENNKE HG: Structural alterations associated with glomerular hyperfiltration, in The Progressive Nature of Renal Disease, edited by MITCH WE, BRENNER BM, STEIN JH, New York, Churchill Livingstone, 1986, pp. 111-131
10. RENNKE HG, KLEIN PS: Pathogenesis and significance qf nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 13:443-456, 1989
11. DIAMOND JR, KARNOVSKY MJ: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 33:917-924, 1988
12. GROND J, KOUDSTAAL J, ELEMA JD: Mesangial function and glomerular sclerosis in rats with aminonucleoside nephrosis. Kidney Int 27:405-410, 1985
13. KEANE WF, RAIJ L: Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules. Lab Invest 52:599-604, 1985
14. SCHREINER GF: Pathways leading from glomerular injury to glomerulosclerosis. Contrib Nephrol 86:1-18, 1990
15. MOORHEAD JF, CHAN MK, VARGHESE Z: The role of abnormalities of lipid metabolism in the progression of renal disease, in The Progressive Nature of Renal Disease, edited by MITCH WE, BRENNER BM, STEIN JH, New York, Churchill Livingstone, 1986, pp. 133-149
16. SCHMITZ PG, KASISKE BL, O'DONNELL MP, KEANE WF: Lipids and progressive renal injury. Sem Nephrol 9:354-369, 1989
17. FOGO A, HAWKINS EP, BERRY PL, GLICK AD, CHIANG ML, MACDONELL RC, ICHIKAWA I: Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38:115-123, 1990
18. VAN GOOR H, FIDLER V, WEENING J, GROND J: Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Lab Invest (in press)
19. FLOEGE J, JOHNSON RJ, GORDON K, IIDA H, PRITZL P, YOSHIMURA A, CAMPBELL C, ALPERS CE, COUSER WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int (in press)
20. STAHL RAK, THAISS F, SCHOEPPE W, WENZEL U, HELMCHEN U: Development of progressive glomerular disease in the rat by repetitive injection of an antibody directed to mesangial cells. (abstract) J Am Soc Nephrol 4:642, 1991
21. JOHNSON RJ, GARCIA RL, PRITZL P, ALPERS CE: Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 136:369-374, 1990
22. CATTELL V: Focal mesangial proliferative glomerulonephritis in the rat caused by habu snake venom: The role of platelets. Br J Exp Pathol 60:201-208, 1979
23. PURKERSON ML, JOIST JH, YATES J, VALDES A, MORRISON A, KLAHR S: Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci USA 82:193-197, 1985
24. ZOJA C, PERICO N, CORNA D, BENIGNI A, GABANELLI M, MORIGI M, BERTANI T, REMUZZI G: Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney. J Am Soc Nephrol 1:799-807, 1990
25. ZOJA C, PERICO N, BERGAMELLI A, PASINI M, MORIGI M, DADAN J, BELLONI A, BERTANI T, REMUZZI G: Ticlopidine prevents renal disease progression in rats with reduced renal mass. Kidney Int 37:934-942, 1990
26. PURKERSON ML, TOLLEFSEN DM, KLAHR S: N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. J Clin Invest 81:69-74, 1988
27. ICHIKAWA I, YOSHIDA Y, FOGO A, PURKERSON ML, KLAHR S: Effect of heparin on the glomerular structure and function of remnant nephrons. Kidney Int 34:638-644, 1988
28. Ross R: Platelet-derived growth factor. Lancet I:1179-1182, 1989
29. SILVER BJ, JAFFER FE, ABBOUD HE: Platelet-derived growth factor synthesis in mesangial cells: Induction by multiple peptide mitogens. Proc Natl Acad Sci USA 86:1056-1060, 1988
30. MENE P, SIMONSON MS, DUNN MJ: Physiology of the mesangial cell. Physiol Rev 69:1347-1424, 1989
31. STERZEL RB, LOVETT DH: Interactions of inflammatory and glomerular cells in the response to glomerular injury, in Contemporary Issues of Nephrology 18, edited by BRENNER BM, STEIN JH, WILSON CB, New York, Churchill Livingstone, 1988, pp. 137-173.
32. FLOEGE J, TOPLEY N, RESCH K: Regulation of mesangial cell proliferation. Am J Kidney Dis 17:673-676, 1991
33. IIDA H, SEIFERT R, ALPERS CE, GRONWALD RGK, PHILIPS PE, PRITZL P, GORDON K, GOWN AM, ROSS R, BOWEN-POPE DF, JOHNSON RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA (in press)
34. JOHNSON RJ, IIDA H, ALPERS CE, MAJESKY MW, SCHWARTZ SM, PRITZL P, GORDON K, GOWN AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J Clin Invest 87:847-858, 1991
35. KURKI P, VANDERLAAN M, DOLBEARE F, GRAY J, TAN EM: Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 166:209-219, 1986
36. SEKIYA S, GOTOH S, YAMASHITA T, WATANABE T, SAITOH S, SENDO F: Selective depletion of rat neutrophils by in vivo administration of a monoclonal antibody. J Leukocyte Biol 46:96-102, 1989
37. SHIRAISHI T, MORIMOTO S, ITOH K, SATO H, SUGIHARA K, ONISHI T, OGIHARA T: Radioimmunoassay of human platelet-derived growth factor using monoclonal antibodies toward a synthetic 73-97 fragment of its B-chain. Clin Chim Acta 184:65-74, 1989
38. SKALLI O, ROPRAZ P, TRZECIAK A, BENZONANA G, GILLESSEN D, GABBIANI G: A monoclonal antibody against α-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103:2787-2796, 1986
39. YOSHIMURA A, GORDON K, ALPERS CE, FLOEGE J, PRITZL P, ROSS R, COUSER WG, BOWEN-POPE DF, JOHNSON RJ: Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int (in press)
40. ADLER S, STRIKER LJ, STRIKER GE, PERKINSON DT, HIBBERT J, COUSER WG: Studies of progressive glomerular sclerosis in the rat. Am J Pathol 123:553-562, 1986
41. JOHNSON RJ, ALPERS CE, PRUCHNO C, SCHULZE M, BAKER PJ, PRITZL P, COUSER WG: Mechanisms and kinetics for platelet and neutrophil localization in immune complex nephritis. Kidney Int 36:780-789, 1989
42. JOHNSON RJ, PRITZL P, IIDA H, ALPERS CE: Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol 138:313-321, 1991
43. LEE KH, BOWEN-POPE DF, REED RR: Isolation and characterization of the α platelet-derived growth factor receptor from rat olfactory epithelium. Mol Cell Biol 10:2237-2246, 1990
44. YARDEN Y, ESCOBEDO JA, KUANG WJ, YANG-FENG TL, DANIEL TO, TREMBLE PM, CHEN EY, ANDO ME, HARKINS RN, FRANCKE U, FRIED VA, ULLRICH A, WILLIAMS LT: Structure of the receptor of platelet derived growth factor helps define a family of closely related growth factor receptors. Nature 323:226-232, 1986
45. BRADLEY GM, BENSON ES: Examination of the urine, in Todd-Sanford Clinical Diagnosis by Laboratory Methods, edited by DAVIDSON I, HENRY JB, Philadelphia, WB Saunders, 1974, p. 74
46. WALLENSTEIN S, ZUCKER CL, FLEISS JL: Some statistical methods useful in circulation research. Circ Res 47:1-9, 1980
47. KONDO Y, SHIGEMATSU H, KOBAYASHI Y: Cellular aspects of rabbit Masugi nephritis. II. Progressive glomerular injuries with crescent formation. ref. monocytes may replicate. Lab Invest 27:620-631, 1972
48. VAN FURTH R: Phagocytic cells: Development and distribution of mononuclear phagocytes in normal steady state and inflammation, in Inflammation: Basic Principles and Clinical Correlates, edited by GALLIN JI, GOLDSTEIN IM, SNYDERMAN R, New York, Raven Press, 1982, pp. 281-295
49. HOSTETTER TH, OLSON JL, RENNKE HG, VENKATACHALAM MA, BRENNER BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85-F92, 1981
50. OLSON JL, HEPTINSTALL RH: Nonimmunologic mechanisms of glomerular injury. Lab Invest 59:564-578, 1988
51. FRIES JWU, SANDSTROM DJ, MEYER TW, RENNKE HG: Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 60:205-218, 1989
52. 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologica 25:280-287, 1983
53. PABST R, STERZEL RB: Cell renewal of glomerular cell types in normal rats. An autoradiographic study. Kidney Int 24:626-631, 1983
54. REIDY M, SCHWARTZ SM: A technique to investigate surface morphology and endothelial cell replication of small arteries: A study in acute angiotensin-induced hypertensive rats. Microvasc Res 24:158-167, 1982
55. BORDER WA, OKUDA S, LANGUINA LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. (letter) Nature 346:371-374, 1990
56. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86:453-462, 1990
57. ZOJA C, BENIGNI A, LIVIO M, BERGAMELLI A, ORISIO S, ABBATE M, BERTANI T, REMUZZI G: Selective inhibition of platelet thromboxane does not protect rats with reduced renal mass from the development of progressive disease. Am J Pathol 134:1027-1038, 1989
58. KINLOUGH-RATHBONE RL, CAZENAVE JP, PACKHAM MA, MUSTARD JF: Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent to collagen. Lab Invest 42:28-34, 1980
59. FLOEGE J, TOPLEY N, HOPPE J, BARRETT TB, RESCH K: Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: Modulation and/or suppression by inflammatory cytokines. Clin Exp Immunol (in press)
60. MIYAZONO K, OKABE T, URABE A, TAKAKU F, HELDIN CH: Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262:4098-4103, 1987
61. HSIEH HJ, LI NQ, FRANGOS JA: Shear stress increases endothelial platelet-derived growth factor mRNA levels. Am J Physiol 260: H642-H646, 1991
62. GESUALDO L, PINZANI M, FLORIANO JJ, EMANCIPATOR SN: Platelet derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest (in press)
63. BEITZ JG, KIN IS, CALABRESI P, FRACKELTON AR: Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci USA 88:2021-2025, 1991
64. MOTOJIMA M, IKOMA M, KAWAMURA T, FOGO A, ICHIKAWA I: Effect of dialytic intervention on the function and morphology of glomeruli in rats with progressive renal disease. (abstract) Kidney Int 37:332, 1990
65. FJELLSTRÖM B, KLARESKOG L, HELDIN CH, LARSSON E, RÖNNSTRAND L, TERRACIA L, TUFVESON G, WAHLBERG J, RUBIN K: Platelet-derived growth factor receptors in the kidney - Upregulated expression in inflammation. Kidney Int 36:1099-1102, 1989
66. ROLLINS BJ, YOSHIMURA T, LEONARD EJ, POBER SJ: Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 136:1229-1233, 1990
67. WEISER WY, GREINEDER DK, REMOLD HG, DAVID JR: Studies on human migration inhibitory factor: Characterization of three molecular species. J Immunol 126:1958-1963, 1981
68. GOMEZ RS, DIEPGEN TL, NEUMANN C, SORG C: Detection of migration inhibitory factor by a monoclonal antibody in the microvasculature of inflamed skin. Arch Dermatol Res 282:374-378, 1990
69. ROVIN BH, LEFKOWITH JB, LANGE L, SCHREINER GF: Glomerular production of a lipid monocyte chemotactic factor. (abstract) J Am Soc Nephrol 1:536, 1990